Risk Factors for Recurrence of the Anti‐Synthetase Syndrome Related Interstitial Lung Disease
Immunity, Inflammation and Disease · 2026-04 · 14 (4)
DOI: 10.1002/iid3.70417 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 20.04.2026. Verfasst von Zhen-Yu Ren und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Myositis. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
This current study aimed to detect the risk factors for recurrence of the anti‐synthetase syndrome related interstitial lung disease (ASSD‐ILD).
Methods
Patients who were diagnosed with ASSD‐ILD and achieved the improving standards after treatment at a single clinical center from January 1, 2017 to January 1, 2022 were retrospectively collected. The patients were divided into the recurrence group and non‐recurrence group. We compared the baseline information, pulmonary function test, chest computed tomography/high‐resolution computed tomography (CT/HRCT) images, and treatments et al between the two groups. Cox regression was performed to find risk factors for recurrence. Moreover, the Kaplan‐Meier curve was conducted to estimate the recurrence‐free rate.
Results
Totally 76 ASSD‐ILD patients were collected in this study. There were 24 patients in the recurrence group and 52 patients in the non‐recurrence group. The recurrence rate was 31.6%. Univariate analysis showed that pyrexia of unknown origin, neutrophil percentage > 75%, non‐specific interstitial pneumonia (NSIP) alone pattern, and immunosuppressants discontinuation were associated with recurrence ( p < 0.05). In the primary IPTW‐weighted Cox model, pyrexia of unknown origin was significantly associated with recurrence (HR = 2.70, 95% CI: 1.12–6.51, p = 0.027). In sensitivity analyses using a doubly robust IPTW‐weighted Cox model, both pyrexia of unknown origin (HR = 5.17, 95% CI: 1.94–13.78, p = 0.001) and NSIP alone pattern (HR = 0.30, 95% CI: 0.11–0.80, p = 0.016) remained significantly associated with recurrence. Furthermore, the Kaplan‐Meier curve demonstrated that the non‐NSIP group ( p = 0.039) and the pyrexia of unknown origin group ( p = 0.023) had worse recurrence‐free rate.
Conclusion
Among patients with ASSD‐ILD there is a high frequency of recurrence. The results suggested that pyrexia of unknown origin was a risk factor for recurrence. A follow‐up strategy, customized treatment, and early surveillance for high‐risk patients who relapse were critical to enhancing patients' quality of life and prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Chongqing Red Cross Hospital, Chongqing, China.
ORCID-Profile: Zhen-Yu Ren
Zitieren
APA
Ren, Z. Y., Yang, X., Yang, J., Kou, P., & Tang, X. K. (2026). Risk Factors for Recurrence of the Anti‐Synthetase Syndrome Related Interstitial Lung Disease. Immunity, Inflammation and Disease, 14(4). https://doi.org/10.1002/iid3.70417
Vancouver
Ren ZY, Yang X, Yang J, Kou P, Tang XK. Risk Factors for Recurrence of the Anti‐Synthetase Syndrome Related Interstitial Lung Disease. Immunity, Inflammation and Disease. 2026;14(4). doi:10.1002/iid3.70417
BibTeX
@article{Ren2026,
author = {Ren, Zhen-Yu and Yang, Xue and Yang, Jing and Kou, Ping and Tang, Xiao-Kui},
title = {Risk Factors for Recurrence of the Anti‐Synthetase Syndrome Related Interstitial Lung Disease},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {4},
doi = {10.1002/iid3.70417}
}
EUVIMED